569 |
Understanding of Clinical Trials in Interventional Cardiology: Trial Design Issues |
Ajay J. Kirtane |
Oct. 02. 08 |
568 |
CARESS-in-AMI |
Carlo Di Mario |
Sep. 26. 08 |
567 |
Treatment Modalities for Diagnosing and Treatment of Vulnerable Plaque |
Ron Waksman |
Sep. 26. 08 |
566 |
Reconciling Angiographic and Clinical Results After Stent Treatment: A Critical Appraisal and Recommendations for Clinical Assessments of Future Stents |
Jeffrey J. Popma |
Sep. 26. 08 |
565 |
Drug Eluting Stents: How Can We Know If "Newer" Is Actually "Better"? |
Mitchell W. Krucoff |
Sep. 26. 08 |
564 |
The Complex Relation Between Vulnerability and Ischemia |
Nico Pijls |
Sep. 26. 08 |
563 |
Current Management of ACS |
Robbert De Winter |
Sep. 26. 08 |
562 |
Which Patients Are Good Candidate for Carotid Artery Stenting or Carotid Endarterectomy? |
Michael R. Jaff |
Sep. 26. 08 |
561 |
Does PCI Reduce Mortality? A Meta-Analysis of 17 Studies Comparing PCI (Bare Metal and Drug-Eluting Stents) vs. Medical Therapy |
Adnan Kastrati |
Sep. 26. 08 |
560 |
[Debate] Which one Is the Best Choice in Left Main Revascularization?: : CABG Is the Best Choice. |
David Paul Taggart |
Sep. 26. 08 |